Protein Adducts of Aldehydic Lipid Peroxidation Products: Identification and Characterization of Protein Adducts Using an Aldehyde/Keto-Reactive Probe in Combination with Mass Spectrometry

Methods in Enzymology

Volumn 473, Issue , 2010, Pages 305-330

  Maier, Claudia S ^a   Chavez, Juan ^a   Wang, Jing ^a   Wu, Jianyong ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; KETONE; PROTEIN; REACTIVE OXYGEN METABOLITE;

ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; GENETIC PROCEDURES; HUMAN; LIPID PEROXIDATION; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; PHYSIOLOGY; REVIEW; STAINING;

ALDEHYDES; ANIMALS; BIOSENSING TECHNIQUES; HUMANS; KETONES; LIPID PEROXIDATION; MASS SPECTROMETRY; MODELS, BIOLOGICAL; PROTEINS; REACTIVE OXYGEN SPECIES; STAINING AND LABELING;

EID: 77956211745     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/S0076-6879(10)73016-0     Document Type: Chapter

References (65)

1. Beckman, K.B., Ames, B.N., The free radical theory of aging matures. Physiol. Rev. 78 (1998), 547–581.
2. Berlett, B.S., Stadtman, E.R., Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272 (1997), 20313–20316.
3. Bieschke, J., et al. Small molecule oxidation products trigger disease-associated protein misfolding. Acc. Chem. Res. 39 (2006), 611–619.
4. Brookes, P.S., et al. Calcium, ATP, and ROS: A mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 287 (2004), C817–C833.
5. Brooks, J.D., et al. Formation of highly reactive cyclopentenone isoprostane compounds (A3/J3-isoprostanes) in vivo from eicosapentaenoic acid. J. Biol. Chem. 283 (2008), 12043–12055.
6. Butterfield, D.A., Sultana, R., Redox proteomics: Understanding oxidative stress in the progression of age-related neurodegenerative disorders. Expert Rev. Proteomics 5 (2008), 157–160.
7. Carbone, D.L., et al. 4-Hydroxynonenal regulates 26S proteasomal degradation of alcohol dehydrogenase. Free Radic. Biol. Med. 37 (2004), 1430–1439.
8. Carbone, D.L., et al. Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase. Chem. Res. Toxicol. 18 (2005), 1324–1331.
9. Catalá, A., Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem. Phys. Lipids 157 (2009), 1–11.
10. Chavez, J., et al. New role for an old probe: Affinity labeling of oxylipid protein conjugates by N'-aminooxymethylcarbonylhydrazino D-biotin. Anal. Chem. 78 (2006), 6847–6854.
11. Chavez, J., et al. Site-specific protein adducts of 4-hydroxy-2(E)-nonenal in human THP-1 monocytic cells: Protein carbonylation is dimished by ascorbic acid. Chem. Res. Toxicol. 23 (2010), 37–47.
12. Chen, Y., et al. Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway. J. Biol. Chem. 274 (1999), 10863–10868.
13. Chung, W.-G., et al. Hop proanthocyanidins induce apoptosis, protein carbonylation, and cytoskeleton disorganization in human colorectal adenocarcinoma cells via reactive oxygen species. Food Chem. Toxicol. 47 (2009), 827–836.
14. Codreanu, S.G., et al. Global analysis of protein damage by the lipid electrophile 4-hydroxy-2-nonenal. Mol. Cell. Proteomics 8 (2009), 670–680.
15. Crompton, M., The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341:Pt 2 (1999), 233–249.
16. Crompton, M., et al. The mitochondrial permeability transition pore. Biochem. Soc. Symp. 66 (1999), 167–179.
17. Danni, L.M., et al. Identification of carbonylated proteins from enriched rat skeletal muscle mitochondria using affinity chromatography-stable isotope labeling and tandem mass spectrometry. Proteomics 7 (2007), 1150–1163.
18. David, N.P., et al. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20 (1999), 3551–3567.
19. Dmitriev, L.F., The involvement of lipid radical cycles and the adenine nucleotide translocator in neurodegenerative diseases. J. Alzheimers Dis. 11 (2007), 183–190.
20. Doorn, J.A., Petersen, D.R., Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal. Chem. Biol. Interact. 143–144 (2003), 93–100.
21. Eliuk, S.M., et al. Active site modifications of the brain isoform of creatine kinase by 4-hydroxy-2-nonenal correlate with reduced enzyme activity: Mapping of modified sites by fourier transform-ion cyclotron resonance mass spectrometry. Chem. Res. Toxicol. 20 (2007), 1260–1268.
22. Esterbauer, H., et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 (1991), 81–128.
23. Farout, L., et al. Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch. Biochem. Biophys. 453 (2006), 135–142.
24. Finkel, T., Holbrook, N.J., Oxidants, oxidative stress and the biology of ageing. Nature 408 (2000), 239–247.
25. Furuhata, A., et al. Thiolation of protein-bound carcinogenic aldehyde. J. Biol. Chem. 277 (2002), 27919–27926.
26. Han, D., et al. Sites and mechanisms of aconitase inactivation by peroxynitrite: Modulation by citrate and glutathione. Biochemistry 44 (2005), 11986–11996.
27. Han, B., et al. Design, synthesis, and application of a hydrazide-functionalized isotope-coded affinity tag for the quantification of oxylipid-protein conjugates. Anal. Chem. 79 (2007), 3342–3354.
28. Helga, S., et al. Genomic damage in end-stage renal failure: Potential involvement of advanced glycation end products and carbonyl stress. Semin. Nephrol. 24 (2004), 474–478.
29. Ichihashi, K., et al. Endogenous formation of protein adducts with carcinogenic aldehydes. J. Biol. Chem. 276 (2001), 23903–23913.
30. Kim, H.-Y.H., et al. An azido-biotin reagent for use in the isolation of protein adducts of lipid-derived electrophiles by streptavidin catch and photorelease. Mol. Cell. Proteomics 8 (2009), 2080–2089.
31. Landar, A., et al. Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. Am. J. Physiol. Heart Circ. Physiol. 290 (2006), H1777–H1787.
32. Lee, H.P., et al. The essential role of ERK in 4-oxo-2-nonenal-mediated cytotoxicity in SH-SY5Y human neuroblastoma cells. J. Neurochem. 108 (2009), 1434–1441.
33. Lin, D., et al. 4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-Hydroxy-2-nonenal. Chem. Res. Toxicol. 18 (2005), 1219–1231.
34. Liu, Z., et al. Mass spectroscopic characterization of protein modification by 4-Hydroxy-2-(E)-nonenal and 4-Oxo-2-(E)-nonenal. Chem. Res. Toxicol. 16 (2003), 901–911.
35. Maisonneuve, E., et al. Rules governing selective protein carbonylation. PLoS One, 4, 2009, e7269.
36. Marley, K., et al. Mass tagging approach for mitochondrial thiol proteins. J. Proteome Res. 4 (2005), 1403–1412.
37. Mirzaei, H., Regnier, F., Enrichment of carbonylated peptides using Girard P reagent and strong cation exchange chromatography. Anal. Chem. 78 (2005), 770–778.
38. Mirzaei, H., Regnier, F., Identification of yeast oxidized proteins: Chromatographic top-down approach for identification of carbonylated, fragmented and cross-linked proteins in yeast. J. Chromatogr. A 1141 (2007), 22–31.
39. Montine, T.J., et al. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic. Biol. Med. 33 (2002), 620–626.
40. Nicotera, P., et al. Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol. Lett. 102–103 (1998), 139–142.
41. Oe, T., et al. A novel lipid hydroperoxide-derived cyclic covalent modification to histone H4. J. Biol. Chem. 278 (2003), 42098–42105.
42. Oe, T., et al. A novel lipid hydroperoxide-derived modification to arginine. Chem. Res. Toxicol. 16 (2003), 1598–1605.
43. Poli, G., et al. 4-Hydroxynonenal-protein adducts: A reliable biomarker of lipid oxidation in liver diseases. Mol. Aspects Med. 29 (2008), 67–71.
44. Powell, S.R., et al. Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins. Free Radic. Biol. Med. 38 (2005), 1093–1101.
45. Qin, Z., et al. Effect of 4-hydroxy-2-nonenal modification on α-synuclein aggregation. J. Biol. Chem. 282 (2007), 5862–5870.
46. Rauniyar, N., et al. Characterization of 4-hydroxy-2-nonenal-modified peptides by liquid chromatography-tandem mass spectrometry using data-dependent acquisition: Neutral loss-driven MS3 versus neutral loss-driven electron capture dissociation. Anal. Chem. 81 (2008), 782–789.
47. Reed, T.T., et al. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD. Brain Res. 1274 (2009), 66–76.
48. Roe, M.R., et al. Proteomic mapping of 4-hydroxynonenal protein modification sites by solid-phase hydrazide chemistry and mass spectrometry. Anal. Chem. 79 (2007), 3747–3756.
49. Roede, J.R., et al. In vitro and in silico characterization of peroxiredoxin-6 modified by 4-hydroxynonenal and 4-oxononenal. Chem. Res. Toxicol. 21 (2008), 2289–2299.
50. Sayre, L.M., et al. Protein adducts generated from products of lipid oxidation: Focus on HNE and one. Drug Metab. Rev. 38 (2006), 651–675.
51. Shin, N.-Y., et al. Protein targets of reactive electrophiles in human liver microsomes. Chem. Res. Toxicol. 20 (2007), 859–867.
52. Shonsey, E.M., et al. Inactivation of human liver bile acid CoA:amino acid N-acyltransferase by the electrophilic lipid, 4-hydroxynonenal. J. Lipid Res. 49 (2008), 282–294.
53. Spiteller, G., Lipid peroxidation in aging and age-dependent diseases. Exp. Gerontol. 36 (2001), 1425–1457.
54. Spiteller, P., et al. Aldehydic lipid peroxidation products derived from linoleic acid. Biochim. Biophys. Acta 1531 (2001), 188–208.
55. Stevens, J.F., Maier, C.S., Acrolein: Sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 52 (2008), 7–25.
56. Stewart, B.J., et al. Residue-specific adduction of tubulin by 4-hydroxynonenal and 4-oxononenal causes cross-linking and inhibits polymerization. Chem. Res. Toxicol. 20 (2007), 1111–1119.
57. Suh, J.H., et al. Two subpopulations of mitochondria in the aging rat heart display heterogenous levels of oxidative stress. Free Radic. Biol. Med. 35 (2003), 1064–1072.
58. Sultana, R., et al. Proteomics identification of oxidatively modified proteins in brain. Proteomics, 2009, 291–301.
59. Uchida, K., Role of reactive aldehyde in cardiovascular diseases. Free Radic. Biol. Med. 28 (2000), 1685–1696.
60. Vila, A., et al. Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives. Chem. Res. Toxicol. 21 (2008), 432–444.
61. West, J.D., Marnett, L.J., Endogenous reactive intermediates as modulators of cell signaling and cell death. Chem. Res. Toxicol. 19 (2006), 173–194.
62. Williams, M.V., et al. Covalent adducts arising from the decomposition products of lipid hydroperoxides in the presence of cytochrome c. Chem. Res. Toxicol. 20 (2007), 767–775.
63. Wong, H.L., Liebler, D.C., Mitochondrial protein targets of thiol-reactive electrophiles. Chem. Res. Toxicol. 21 (2008), 796–804.
64. Zhang, W.-H., et al. Model studies on protein side chain modification by 4-Oxo-2-nonenal. Chem. Res. Toxicol. 16 (2003), 512–523.
65. Zhu, X., Sayre, L.M., Long-lived 4-oxo-2-enal-derived apparent lysine Michael adducts are actually the isomeric 4-ketoamides. Chem. Res. Toxicol. 20 (2007), 165–170.